keyboard_arrow_up

Cell-Based Assay Market worth $14.8 Billion by 2018

The report “Cell-Based Assays Market by Application (Drug Discovery, ADMET), Product [(Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services)], End-user (Pharmaceutical, CRO) - Global Forecast to 2018”, the global cell-based assays market is growing at a CAGR of 11.1% from 2013 to 2018 and poised to reach $14.8 billion by 2018.


Browse 88 market data Tables and 20 Figures spread through 243 Pages and in-depth TOC on "Cell-Based Assays Market"

http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Early buyers will receive 10% customization on this report.

 

This report studies the global cell-based assays market over the forecast period of 2013 to 2018.

 

The major market propellants for cell-based assays are benefits of cell-based assays over biochemical assays and animal models and public-private partnerships for drug discovery. The growth market is also driven by continuous innovations and developments in the market aimed at higher throughput. The opportunities for the growth of this market include developments in emerging markets such as Asia, introduction of technologically advanced products, and increase need of toxicity screening.

 

Ask For The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=119917269

 

However, factors such as intellectual property rights are restricting innovation in the market and hence hindering growth. The optimization of assay for cell-based assay is still a challenge while complexity of HTS assays and assay standardization and validation is still an unmet need. However, some revolutionary platforms like label-free technology, 3D assays, induced pluripotent stem cells are expected to gain traction in future.

 

This research report categorizes and analyzes the global market on the basis of products, applications, end-users and geography in the market. All these markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2011, 2012, 2013, and forecast to 2018. Based on the cell-based assay product type, consumables (assay kits, reagents, microplates, cell lines), detection and screening instruments, automation and high throughput screening instruments, software and services form the overall market. Under applications market for cell-based assay drug discovery, ADME studies, predictive toxicology and basic research are covered. The end-users market covers academic and government institutions, pharmaceutical and biotechnology companies, and contract research organizations.

 

North America accounted for the largest market share of the market, followed by Europe, in 2013. However, Asia presents significant opportunities for investors as the developed markets get saturated.

 

You can speak To Research Analyst to know more about Report:

http://www.marketsandmarkets.com/requestsample.asp?id=119917269

 

The major players included in this report are BD Biosciences (U.S.) , Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K.), Life Technologies Corporation (U.S.), PerkinElmer (U.S.), and Promega Corporation (U.S.).

 

Browse Related Reports:

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018.

http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

 

 Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018.

http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

 

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets